India to Malta: Paclitaxel Export Trade Route
India has recorded 89 verified shipments of Paclitaxel exported to Malta, representing a combined trade value of $2.1M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $23.5K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 84% of total export value with 72 shipments worth $1.8M USD. On the buying side, EUGIA PHARMA (MALTA) LTD is the largest importer in Malta with $519.5K USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED , INTAS PHARMACEUTICALS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Malta Paclitaxel corridor is one of India's established pharmaceutical export routes, with 89 shipments documented worth a combined $2.1M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 84% of all export value, reflecting the consolidated nature of India's paclitaxel manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $23.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 12.5%, placing it at rank #15 among India's top paclitaxel export destinations globally.
On the import side, key buyers of Indian paclitaxel in Malta include EUGIA PHARMA (MALTA) LTD, APL SWIFT SERVICES (MALTA) LTD, EUGIA PHARMA ( MALTA ) LTD and 10 others. EUGIA PHARMA (MALTA) LTD is the single largest importer with 25 shipments valued at $519.5K USD.
